Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

Article

October 3, 2008

Merz USA names new president and CEO

Greensboro, N.C. - Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to dbusinessnews.com.

Greensboro, N.C.

- Jack Britts, who was previously a pharmaceutical executive at Sepracor and AstraZeneca PLC, has been named President and CEO of Merz Pharmaceuticals, according to

dbusinessnews.com

Mr. Britts will oversee the medical dermatology business, as well as establish two new product avenues in aesthetics and neurology.

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!